A Suffolk County woman who used the biologic drug Enbrel for years to treat arthritis, and who alleges it eventually caused her tongue cancer, may not recover for any injuries that occurred from her use of the medication during a clinical trial, a state appeals court has ruled.

An Appellate Division, First Department panel said “as the sponsors of a clinical trial, [Enbrel’s manufacturers] owed no duty to plaintiff Lauren Wholey, an enrollee in the trial,” citing to two U.S. Court of Appeals for the Sixth Circuit decisions, Sykes v. United States (2012) and Abney v. Amgen (2006).